RTW Biotech Opportunities invests in Alesta Therapeutics’ €65 million series A round
LONDON: RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company focusing on high-growth potential assets in the life sciences sector, has announced a new...
RTW Biotech Opportunities invests in Mirador Therapeutics and Santa Ana Bio
LONDON: RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector,...
Lycia Therapeutics completes $106.6 million Series C financing
LONDON: RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector,...